Patents by Inventor Tamas Koltai

Tamas Koltai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of ibandronic acid and processes for preparation thereof
    Publication number: 20080009466
    Abstract: The invention relates to solid crystalline forms of ibandronic acid, pharmaceutical formulations thereof, and methods of treatment therewith.
    Type: Application
    Filed: April 25, 2007
    Publication date: January 10, 2008
    Inventors: Sharon Avhar-Maydan, Eyal Gilboa, Tamas Koltai, Revital Lifshitz-Liron
  • Crystalline ziprasidone HCI and processes for preparation thereof
    Publication number: 20070238738
    Abstract: Provided is crystalline ziprasidone HCl and processes for preparation thereof.
    Type: Application
    Filed: May 16, 2007
    Publication date: October 11, 2007
    Inventors: Anna Balanov, Judith Aronhime, Boaz Gome, Tamas Koltai, Natalia Shenkar, Marioara Mendelovici, Ehud Amir
  • Maleate salt of tegaserod and crystalline forms thereof
    Publication number: 20070208072
    Abstract: Provided is sesqui-tegaserod maleate and processes for preparation thereof.
    Type: Application
    Filed: January 18, 2007
    Publication date: September 6, 2007
    Inventors: Gustavo Frenkel, Santiago Ini, Tamas Koltai
  • DNT-fumarate and methods of preparation thereof
    Publication number: 20070191471
    Abstract: (S)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine fumarate (DNT-fumarate) and polymorphs of DNT-fumarate, compositions of DNT-fumarate and its polymorphs, processes for the preparation of DNT-fumarate and its polymorphs, and processes for the preparation of duloxetine hydrochloride from DNT-fumarate are provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: August 16, 2007
    Inventors: Santiago Ini, Anita Liberman, Mili Abramov, Tamas Koltai
  • DNT-maleate and methods of preparation thereof
    Publication number: 20070185192
    Abstract: (S)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine maleate (DNT-maleate) and polymorphs of DNT-maleate, compositions of DNT-maleate and its polymorphs, processes for the preparation of DNT-maleate and its polymorphs, and processes for the preparation of duloxetine hydrochloride from DNT-maleate are provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: August 9, 2007
    Inventors: Santiago Ini, Anita Liberman, Mili Abramov, Tamas Koltai
  • DNT-benzenesulfonate and methods of preparation thereof
    Publication number: 20070173540
    Abstract: (S)—N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine benzenesulfonate (DNT-benzenesulfonate) and polymorphs of DNT-benzenesulfonate, compositions of DNT-benzenesulfonate and its polymorphs, processes for the preparation of DNT-benzenesulfonate and its polymorphs, and processes for the preparation of duloxetine hydrochloride from DNT-benzenesulfonate are provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: July 26, 2007
    Inventors: Santiago Ini, Mili Abramov, Tamas Koltai
  • DNT-succinate and methods of preparation thereof
    Publication number: 20070173541
    Abstract: (S)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine succinate (DNT-succinate) and polymorphs of DNT-succinate, compositions of DNT-succinate and its polymorphs, processes for the preparation of DNT-succinate and its polymorphs, and processes for the preparation of duloxetine hydrochloride from DNT-succinate are provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: July 26, 2007
    Inventors: Santiago Ini, Mili Abramov, Tamas Koltai
  • Polymorphic forms of tegaserod maleate
    Publication number: 20070112057
    Abstract: Provided are crystalline forms of tegaserod maleate and processes for the preparation thereof.
    Type: Application
    Filed: June 22, 2006
    Publication date: May 17, 2007
    Inventors: Santiago Ini, Tamas Koltai, Michael Pinchasov, Sofia Gorohovsky, Gustavo Frenkel
  • Methods for preparation of ladostigil tartrate crystalline form A1
    Publication number: 20070093549
    Abstract: Provided are processes for preparing crystalline ladostigil tartrate form A1.
    Type: Application
    Filed: September 28, 2006
    Publication date: April 26, 2007
    Inventors: Judith Aronhime, Eliezer Bahar, Anton Frenkel, Ronen Gottesfeld, Tamas Koltai
  • Polymorphic forms of ladostigil tartrate
    Publication number: 20070088082
    Abstract: Provided are polymorphic forms of ladostigil tartrate and methods for preparation thereof.
    Type: Application
    Filed: September 28, 2006
    Publication date: April 19, 2007
    Inventors: Judith Aronhime, Eliezer Bahar, Anton Frenkel, Ronen Gottesfeld, Amir Gold, Tamas Koltai
  • Crystal forms of (S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof
    Publication number: 20060270860
    Abstract: DNT-Oxal crystalline forms and processes for making DNT-Oxal crystalline forms are provided.
    Type: Application
    Filed: March 8, 2006
    Publication date: November 30, 2006
    Inventors: Santiago Ini, Anita Liberman, Tamas Koltai
  • Duloxetine HCl polymorphs
    Publication number: 20060270859
    Abstract: A crystalline form of duloxetine hydrochloride, pharmaceutical compositions of the crystalline form of duloxetine hydrochloride, and methods of preparing the crystalline form of duloxetine hydrochloride are provided.
    Type: Application
    Filed: January 27, 2006
    Publication date: November 30, 2006
    Inventors: Santiago Ini, Yaron Shmuel, Tamas Koltai, Amir Gold
  • Process for preparing amorphous valsartan
    Publication number: 20060270723
    Abstract: The present invention provides a process for the preparation of amorphous valsartan.
    Type: Application
    Filed: January 11, 2006
    Publication date: November 30, 2006
    Inventors: Tamas Koltai, Omer Malachi, Nisim Sasson, Amir Gold
  • Amorphous tegaserod maleate
    Publication number: 20060258633
    Abstract: Provided are amorphous and purely amorphous tegaserod maleate and processes for the preparation thereof. Also provided are pharmaceutical compositions comprising amorphous or purely amorphous tegaserod maleate and methods for the treatment of irritable bowel syndrome using the same.
    Type: Application
    Filed: March 8, 2006
    Publication date: November 16, 2006
    Inventors: Santiago Ini, Michael Pinchasov, Tamas Koltai, Judith Aronhime
  • (S)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof
    Publication number: 20060258871
    Abstract: The invention provides (S)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine-Di-p-toluoyl-L-tartarate (DNT-L-pTTA), which can be used as an intermediate in the preparation of duloxetine hydrochloride, processes for the preparation of DNT-L-pTTA, a crystalline form of DNT-L-pTTA, and processes for the preparation of duloxetine hydrochloride form DNT-L-pTTA.
    Type: Application
    Filed: March 14, 2006
    Publication date: November 16, 2006
    Inventors: Santiago Ini, Tamas Koltai, Mili Abramov
  • Crystalline forms of linezolid intermediate
    Publication number: 20060258655
    Abstract: The present invention relates to novel crystalline forms of the linezolid intermediate S—N-(4-morpholinyl-3-fluorophenyl)-2-oxo-5-oxazolidinyl-methyl amine referred to herein as Form A, Form B, and Form C.
    Type: Application
    Filed: February 24, 2006
    Publication date: November 16, 2006
    Inventors: Tamas Koltai, Tamar Nidam, Viviana Braude, Serguei Fine
  • Zolmitriptan crystal forms
    Publication number: 20060241160
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: June 19, 2006
    Publication date: October 26, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Zolmitriptan crystal forms
    Publication number: 20060241159
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: June 19, 2006
    Publication date: October 26, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Zolmitriptan crystal forms
    Publication number: 20060241158
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: June 19, 2006
    Publication date: October 26, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo
  • Zolmitriptan crystal forms
    Publication number: 20060211751
    Abstract: The invention encompasses novel crystalline forms of zolmitriptan herein defined as Form B, D, C, E, F, G, H, I, J, K, M, N, O, P, Q, R, S, or Amorphous and to methods of making thereof. The invention also encompasses methods of making zolmitriptan crystalline Form A.
    Type: Application
    Filed: November 21, 2005
    Publication date: September 21, 2006
    Inventors: Reuven Izsak, Ori Lerman, Tamas Koltai, Judith Aronhime, Michael Pinchasov, Hagit Eisen-Nevo